Navigation Links
Loxo Oncology And Array BioPharma Announce License And Collaboration Agreement
Date:7/10/2013

making excellent progress and we expect to initiate human clinical trials in 2014," said Josh Bilenker, MD, Loxo chief executive officer and a partner in Aisling Capital.  

Array has a consistent track record of successful drug discovery with extensive capabilities in high throughput lead identification, protein-structure-enabled drug design, and diverse chemistry approaches such as competitive, allosteric and covalent target inhibition.  Array has invented 16 drugs which are in clinical development, including 11 currently in Phase 2 or 3 trials. Beyond its wholly-owned hematology/oncology programs, Array has partnered development of Array-invented drugs with companies including Amgen, Astra Zeneca, Celgene, Genentech, Novartis and Oncothyreon.

"We are delighted to enter into this collaboration with the goal of rapidly bringing this exciting technology to cancer patients," said Ron Squarer, chief executive officer, Array BioPharma.  "Array has partnered with a number of venture-backed companies which continue to produce encouraging results; the venture-financed model of drug discovery and development can cost-effectively identify novel candidates and rapidly test the clinical hypothesis." 

As part of the formation of Loxo Oncology, Keith Flaherty, MD, the director of the Henri and Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital, will chair the company's Scientific Advisory Board.  "Having collaborated with small and large companies, I consider Loxo to be ideally constructed to rapidly translate emerging validated targets into therapies.
This collaboration provides a unique opportunity to work with Array chemists and biologists to direct novel agents targeting critical points of signal transduction in cancer to biomarker-defined cancer populations for whom a significant unmet need persists."

Dennis Pu
'/>"/>

SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
2. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
3. PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications
4. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
5. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
6. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
7. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
8. Genomic Health Announces Results of Ten Studies in Breast, Prostate and Colon Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
10. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Holding Company (Nasdaq: ESRX ) announced 2015 second ... $600.1 million, or $0.88 per diluted share.  Adjusted earnings ... $1.44 for the second quarter. 1  ... validating the need for size and scale," said George ... most is how that size and scale is leveraged. ...
(Date:7/28/2015)... On the afternoon of August 11, 2015, ... International, Inc. (CPI), plans to file its Form 10-Q ... the Securities and Exchange Commission and to issue a ... 11 a.m. (EDT) on Wednesday, August 12, 2015, CPI ... this release that will be Web cast simultaneously on ...
(Date:7/28/2015)... DUBLIN , July 28, 2015 Research ... of the "Refurbished Medical Equipment Market - Global ... The global refurbished medical equipment market is estimated ... at a CAGR of 12.5% from 2014 to 2019. ... for low-cost medical devices due to financial constraints, increasing ...
Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25CPI International To Announce Third Quarter 2015 Financial Results 2Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2
... ORANGE, Calif., Feb. 23, 2011 ... $4.6 billion not-for-profit Catholic healthcare system based in Orange, CA ... West Texas and Eastern New Mexico, has selected Care Management™ ... MDRX ) to streamline patient movement through their 14 hospitals ...
... 23, 2011 Healthpoint today announced the launch of ... Healthpoint Biotherapeutics, along with an updated brandmark and corporate ... identity is designed to communicate the company,s commitment to ... ultimately contribute to improved outcomes and quality of life ...
Cached Medicine Technology:St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 2St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 3St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 4St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 5Healthpoint Launches New Corporate Identity 2Healthpoint Launches New Corporate Identity 3
(Date:7/29/2015)... ... July 29, 2015 , ... The New Foundation AZ recently started ... end will cost the 501(c) organization nearly $1 million, will both update the facilities’ ... “We took it down to the studs,” said Geraldine Leary, the New Foundation AZ ...
(Date:7/29/2015)... ... July 29, 2015 , ... The Woodlands and Spring Fit ... while donating to worthy charitable causes each month. The new system will track each ... For each Check In at each facility, the boot camps will donate 20 cents ...
(Date:7/29/2015)... ... July 29, 2015 , ... HealthPostures ( https://healthpostures.com ... partnership with 247Ergo, an ergonomics specialty firm. Purpose of the partnership is to ... companies undertake could improve worker mobility, functionality and fitness levels. , Executives ...
(Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for basketball, ... the home of Zerorez Indianapolis, which plans to expand across the state. , Ray ... our second full year in business and we should double our first year’s revenue. ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... first dermatologist in Sarasota to be chosen by the manufacturer to offer and ... the first injectable, non-invasive way to treat and eliminate double chin fat,” Dr. ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3
... The State Commander of the Indiana American Legion reacted ... the face" to supporters of the Indiana Soldiers and ... Daniels,) request to our Department Adjutant, The American Legion ... shutting down the Home, and what do we get ...
... also used for osteoporosis but not available in U.S., ... Feb. 17 (HealthDay News) -- A large study of ... to prevent osteoporosis, was halted early after researchers found ... recurrent breast cancer among survivors of the disease. , ...
... tested LAS VEGAS, Feb. 17 Chronic kidney disease (CKD), which ... death in the U.S. and it is growing at a steady ... in eight is at risk for developing the disease. CKD is ... symptoms until the kidneys are about to fail. Each year ...
... host the 3rd Annual Atlantic City Casino Blood ... The American Red Cross and the Showboat ... February 25, 2009 to host the 3rd annual ... http://www.newscom.com/cgi-bin/prnh/20090217/DC71647LOGO ) , (Logo: ...
... to have a synergistic effect in the development of ... is a genetic disorder, mostly resulting from mutations in ... metabolism which leads to iron accumulation that may eventually ... between iron metabolism, HFE mutations and alcoholic liver disease ...
... New Orleans, LA Michael Lan, PhD, Professor of Pediatrics ... the senior author of a paper revealing the molecular mechanism ... that make and release insulin. Zinc Finger Transcription Factor ... Cycle Arrest, a paper in press currently available online, will ...
Cached Medicine News:Health News:Legion Condemns Governor's Non-Response to ISSCH Proposal As 'Slap In The Face' 2Health News:Menopause Drug Tied to Breast Cancer Recurrence 2Health News:Task Force Alerting Nevadans to 'Silent' Killer Disease Crisis 2Health News:The American Red Cross Recognizes Atlantic City Casinos 2Health News:LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth 2
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
This unit is the finest standalone handswitch bipolar unit available....
...
...
Medicine Products: